Compare Aurora Cannabis Inc (ACB) vs iShares Russell 2000 ETF (IWM) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

IWM (iShares Russell 2000 ETF) trades at $298.90, up 0.46% with a bullish technical signal supported by moving averages. The ETF holds nearly 2,000 small-cap stocks and has gained 22.1% year-to-date, outperforming major indices. Recent news highlights small-cap strength amid shifting rate expectations, though key financial ratios remain undisclosed in current data.

Outlook remains positive given small-cap momentum and potential rate cuts, but risks include higher volatility and economic sensitivity. The ETF's diversification offers growth exposure, yet investors should weigh valuation concerns and market concentration against historical underperformance versus broad market indices over longer periods.